One goal of researchers is to counter the drug resistance of tumor cells and improve drug sensitivity by modifying the BCRP/ABCG2-mediated, drug-resistant phenotype and the drug-resistant phenotypes of ABC membrane transporter families. The gene discussed is ABCG2; the disease is neoplasm.